Why is Torrent Pharma falling/rising?

As of 21-Jul, Torrent Pharmaceuticals Ltd. is experiencing a slight increase in its stock price, currently at 3,521.00, reflecting a change of 1.95 (0.06%) upwards. The stock has shown strong performance recently, gaining 6.47% over the last six days and outperforming its sector by 0.38%. It is also trading close to its 52-week high, just 1.96% away from Rs 3,589.95. The company has demonstrated high management efficiency with a return on capital employed (ROCE) of 22.33% and has consistently reported positive results for the last seven quarters, which has contributed to its robust performance. However, there are concerns regarding its long-term growth potential, as net sales have only grown at an annual rate of 7.72% over the past five years, and the stock is considered very expensive with a PEG ratio of 2.9.
In the broader market context, Torrent Pharmaceuticals has outperformed the Sensex over various time frames, including a 10.81% increase over the past month compared to a 0.25% decline in the benchmark. This indicates that the stock is gaining traction despite a generally flat market. However, the recent decline in investor participation, with delivery volume falling by 37.57% against the five-day average, may pose a risk to its upward momentum. Overall, while the stock is currently rising, its long-term growth prospects and recent drop in trading volume could impact future performance.